Capacity for research and pre-clinical trials

Orion will have infrastructure and capabilities for pre-clinical trials, which are crucial for developing vaccines, diagnostic methods, and treatments. Analytic infrastructure, ample capacity for cell culture experimentation, capabilities for semi-automated bioassays at various biosafety containment levels, and various animal models for experimenting at biosafety levels 3 and 4 will allow advances in research that could evolve into clinical trials